Quantcast
Last updated on April 18, 2014 at 16:58 EDT

Latest Amerifit Brands Stories

2011-05-25 07:38:00

CROMWELL, Conn., May 25, 2011 /PRNewswire/ -- Each month, millions of women suffer from symptoms associated with premenstrual syndrome (PMS). With the introduction of the all-new AZO PMS(TM) -- the only brand available to address both physiological and emotional symptoms -- women can now get relief from PMS with a fast acting natural product. (Photo: http://photos.prnewswire.com/prnh/20110525/NE08165 ) PMS refers to a wide range of physical and emotional symptoms that typically occur...

2011-02-17 15:45:00

COLUMBIA, Md., Feb. 17, 2011 /PRNewswire/ -- Martek Biosciences Corporation (Nasdaq: MATK), a leader in the innovation, development, production and sales of high-value products from microbial sources that promote health and wellness through nutrition, announced today that it has been inducted into the inaugural Small Business Innovation Research (SBIR) Hall of Fame, a program under the U.S. Small Business Administration. Martek Biosciences was recognized for its success in research,...

2010-12-08 15:00:00

COLUMBIA, Md., Dec. 8, 2010 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) today announced its financial results for the fourth quarter and fiscal year ended October 31, 2010. Total revenues for the fourth quarter were $119.1 million, up 36% from the fourth quarter of fiscal 2009. Fourth quarter non-GAAP earnings per share (EPS) were $0.41, a 24% increase from $0.33 per diluted share in last year's fourth quarter. For the full year 2010, revenues increased 30%...

2010-11-30 08:00:00

COLUMBIA, Md., Nov. 30, 2010 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it intends to release its fourth quarter and fiscal year 2010 financial results on December 8, 2010, at approximately 4:00 p.m. Eastern Time (ET). Following the release, the company will host a conference call and webcast at 4:45 p.m. to discuss the results with investors. All interested parties may listen to the call live via webcast by visiting Martek's web site at...

2010-11-03 15:05:00

COLUMBIA, Md., Nov. 3, 2010 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it will be presenting at the 2010 Citi Small / Mid Cap Conference being held on November 16-17, 2010 in Las Vegas, NV. Steve Dubin, Chief Executive Officer is scheduled to present on Tuesday, November 16 at 10:15 a.m. Pacific Time (1:15 p.m. Eastern Time). A live audio webcast of the presentation can be accessed at:...

2010-09-29 15:00:00

COLUMBIA, Md., Sept. 29 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it will be presenting at the Canaccord Genuity Healthy Living Conference on October 13, 2010 in Boston, MA. Steve Dubin, Chief Executive Officer, and Peter L. Buzy, Chief Financial Officer, are scheduled to present at 09:45 a.m. Eastern Time. A live audio webcast of their presentation can be accessed at: http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=3232680...

2010-09-23 15:06:00

COLUMBIA, Md., Sept. 23 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it has entered into an agreement to sell a significant portion of the assets at its Winchester, Ky., manufacturing site to Alltech, an animal health company headquartered in Nicholasville, Ky. The assets to be sold include a majority of the land and buildings at the Winchester site as well as certain equipment therein, including all of the production-scale fermentation and...

2010-09-08 15:00:00

COLUMBIA, Md., Sept. 8 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation announced today that it will be presenting at the upcoming UBS Global Life Sciences Conference scheduled to take place September 20 - 22, 2010 in New York, NY. Peter L. Buzy, Chief Financial Officer, is scheduled to present on Wednesday, September 22, 2010 at 12:00 p.m. Eastern Time. A live audio webcast of Martek's presentation can be accessed at:...

2010-09-01 15:05:00

COLUMBIA, Md., Sept. 1 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) today announced its financial results for the third quarter of fiscal 2010. Revenues for the third quarter were $117.2 million, up 51% from $77.8 million in the third quarter of fiscal 2009. GAAP net income was $11.9 million, or $0.35 per diluted share, for the third quarter of fiscal 2010, an increase of 33% compared to $8.9 million, or $0.27 per diluted share, for the third quarter of...

2010-08-18 10:45:00

COLUMBIA, Md., Aug. 18 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it intends to release the results of its third quarter of fiscal 2010 on Wednesday, September 1, 2010, at approximately 4:00 p.m. Eastern Time (ET). At 4:45 p.m. ET Martek will conduct a conference call to discuss these results with investors. All interested parties may listen to the call live via webcast by visiting Martek's web site at http://investors.martek.com. An...